✦ LIBER ✦

An anti-IL-2 antibody increases serum halflife and improves anti-tumor efficacy of human recombinant interleukin-2

✍ Scribed by Lynn P. Courtney; Julia L. Phelps; Linda M. Karavodin

Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 714 KB
Volume: 28
Category: Article
ISSN: 0162-3109
DOI: 10.1016/0162-3109(94)90058-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Dualistic effects of cis-diammine-dichlo

Dualistic effects of cis-diammine-dichloro-platinum on the anti-tumor efficacy of subsequently applied recombinant interleukin-2 therapy: A tumor-dependent phenomenon

✍ Moniquc R. Bernsen; A. Peter M. Heintz; Harrold J. J. Van Barungen; Alike W. Van 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 616 KB

The efficacy with which disseminated SL2 and P815 tumors, in syngeneic DBA/2 mice, can be eradicated with low-dose recombinant interleukin-2 (rlL-2) therapy is about equal. Treatment (i.p.) of DBA/2 mice, injected i.p. with SL2 or P8 I5 cells on day 0, with rlL-2 (Proleukin) on days 10 to 14 results

Establishment of an interleukin 6 (IL 6)

Establishment of an interleukin 6 (IL 6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL 6 monoclonal antibodies

✍ Tadashi Matsuda; Toshio Hirano And; Tadamitsu Kishimoto 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 766 KB

Blocking of interleukin 2 (IL 2) binding

Blocking of interleukin 2 (IL 2) binding to the IL 2 receptor is not required for the in vivo action of anti-IL 2 receptor monoclonal antibody (mAb). I. The production, characterization and in vivo properties of a new mouse anti-rat IL 2 receptor mAb that reacts with an epitope different to the one that binds to IL 2 and the mAb ART-18

✍ Athanasia Mouzaki; Hans-Dieter Volk; Hisao Osawa; Tibor Diamantstein 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 727 KB

A mouse anti-rat interleukin 2 (IL 2) receptor (IL 2R) monoclonal antibody (mAb), ART-65, has been developed. As shown by fluorescence-activated cell sorter analysis and immunoprecipitation studies, ART-65 recognizes in a species-specific manner the same molecule as does ART-18, a mAb which has been